Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methylnaltrexone”

48 trials

Showing 20 of 48 results

Not applicableEnded earlyNCT01955213
What this trial is testing

Methylnaltrexone for Opioid Induced Constipation

Who this might be right for
Constipation
Amsterdam UMC, location VUmc 7
Early research (Phase 1)Study completedNCT01367535
What this trial is testing

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

Who this might be right for
Healthy Adults
Bausch Health Americas, Inc. 54
Testing effectiveness (Phase 2)Ended earlyNCT01117376
What this trial is testing

Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients

Who this might be right for
Gastroparesis
Shiraz University of Medical Sciences 42
Post-approval studies (Phase 4)Study completedNCT02403830
What this trial is testing

Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine

Who this might be right for
Coronary Artery Disease
University of Florida 30
Early research (Phase 1)Study completedNCT01596777
What this trial is testing

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects

Who this might be right for
Intestinal Obstruction
University Medicine Greifswald 15
Large-scale testing (Phase 3)UnknownNCT02574819
What this trial is testing

Study of Methylnaltrexone in Opioid-Induced Constipation Patients

Who this might be right for
Opioid-induced Constipation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 198
Early research (Phase 1)Study completedNCT01367522
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

Who this might be right for
Liver Dysfunction
Bausch Health Americas, Inc. 24
Early research (Phase 1)Study completedNCT01366365
What this trial is testing

Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

Who this might be right for
Healthy Adults
Bausch Health Americas, Inc. 28
Large-scale testing (Phase 3)Study completedNCT00387309
What this trial is testing

Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus

Who this might be right for
Post Operative Bowel Dysfunction
Bausch Health Americas, Inc. 495
Early research (Phase 1)Study completedNCT01367496
What this trial is testing

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

Who this might be right for
Healthy Subjects
Bausch Health Americas, Inc. 6
Large-scale testing (Phase 3)Study completedNCT01186770
What this trial is testing

Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc. 804
Post-approval studies (Phase 4)WithdrawnNCT00858754
What this trial is testing

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc.
Early research (Phase 1)Study completedNCT01366326
What this trial is testing

Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects

Who this might be right for
Healthy Adult Subjects
Bausch Health Americas, Inc. 20
Early research (Phase 1)Study completedNCT01367509
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Bausch Health Americas, Inc. 32
Post-approval studies (Phase 4)Study completedNCT02942550
What this trial is testing

Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients

Who this might be right for
STEMIMorphineTicagrelor+1 more
Karolinska University Hospital 82
Early research (Phase 1)Study completedNCT01596764
What this trial is testing

Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.

Who this might be right for
Intestinal Obstruction
University Medicine Greifswald 16
Large-scale testing (Phase 3)Study completedNCT00528970
What this trial is testing

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

Who this might be right for
Ileus
Bausch Health Americas, Inc. 374
Post-approval studies (Phase 4)Study completedNCT01012960
What this trial is testing

Opioids and Esophageal Function

Who this might be right for
Pharyngeal DysfunctionEsophageal Dysfunction
Region Örebro County 13
Large-scale testing (Phase 3)WithdrawnNCT04083651
What this trial is testing

Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Bausch Health Americas, Inc.
Large-scale testing (Phase 3)Study completedNCT00401362
What this trial is testing

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Who this might be right for
Advanced Illness Patients With Opioid Induced Constipation
Bausch Health Americas, Inc. 154
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation